Compare SPCB & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPCB | NMTC |
|---|---|---|
| Founded | 1988 | 2009 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.3M | 43.5M |
| IPO Year | N/A | N/A |
| Metric | SPCB | NMTC |
|---|---|---|
| Price | $10.40 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $2.23 |
| AVG Volume (30 Days) | 120.5K | ★ 365.4K |
| Earning Date | 11-13-2025 | 02-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | ★ $26,739,000.00 | $12,097,692.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $27.13 | $32.08 |
| P/E Ratio | $11.77 | ★ N/A |
| Revenue Growth | N/A | ★ 250.35 |
| 52 Week Low | $5.06 | $0.40 |
| 52 Week High | $14.00 | $1.31 |
| Indicator | SPCB | NMTC |
|---|---|---|
| Relative Strength Index (RSI) | 64.80 | 55.88 |
| Support Level | $8.16 | $0.83 |
| Resistance Level | $9.15 | $0.94 |
| Average True Range (ATR) | 0.65 | 0.06 |
| MACD | 0.24 | -0.01 |
| Stochastic Oscillator | 84.56 | 47.66 |
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.